PubMed · 10421774
Quantitative mechanistically based dose-response modeling with endocrine-active compounds.
Abstract
A wide range of toxicity test methods is used or is being developed for assessing the impact of endocrine-active compounds (EACs) on human health. Interpretation of these data and their quantitative use in human and ecologic risk assessment will be enhanced by the availability of mechanistically based dose-response (MBDR) models to assist low-dose, interspecies, and (italic)in vitro(/italic) to (italic)in vivo(/italic) extrapolations. A quantitative dose-response modeling work group examined the state of the art for developing MBDR models for EACs and the near-term needs to develop, validate, and apply these models for risk assessments. Major aspects of this report relate to current status of these models, the objectives/goals in MBDR model development for EACs, low-dose extrapolation issues, regulatory inertia impeding acceptance of these approaches, and resource/data needs to accelerate model development and model acceptance by the research and the regulatory community.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
M E Andersen, R B Conolly, E M Faustman, R J Kavlock, C J Portier, D M Sheehan, P J Wier, L Ziese. 1999. Quantitative mechanistically based dose-response modeling with endocrine-active compounds.. https://doi.org/10.1289/ehp.99107s4631
Cite the original work for its findings. Save a collection to share your selection of sources.